Oct 25 (Reuters) – BioNTech SE: * BIONTECH AND BRISTOL MYERS SQUIBB REPORT ENCOURAGING GLOBAL PHASE 2 DATA FOR PUMITAMIG IN ADVANCED NSCLC AFTER PROGRESSION ON IMMUNOTHERAPY PLUS CHEMOTHERAPY Source
(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)
Morgan Whittaker scored late in the second half to lift the Colorado Rapids to a…
Oct 25 (Reuters) - BROOKFIELD: * BROOKFIELD- OPENS OFFICE IN DOHA ANCHORED BY ITS GLOBAL…
MOSCOW, Oct 25 (Reuters) - The Russian Defence Ministry said on Sunday that its drones…
VIDEO SHOWS: HIGHLIGHTS OF BASEBALL MLBX EVENT IN MUMBAI WITH BASEBALL LEGENDS LIKE NICK SWISHER,…
Oct 25 (Reuters) - Jiangsu HSC New Energy Materials Co Ltd: * SAYS Q3 NET…
The New York Red Bulls took advantage of an early own goal, added an Emil…